OliX Pharmaceuticals Inc
KOSDAQ:226950
Shareholder Yield
Current shareholder yield for OliX Pharmaceuticals Inc is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
OliX Pharmaceuticals Inc
| Average Annual Return | -10.43% |
| Standard Deviation of Annual Returns | 33.27% |
| Max Drawdown | -83% |
| Market Capitalization | 4.1T KRW |
| Shares Outstanding | 20 190 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
OliX Pharmaceuticals Inc's latest stock split occurred on Dec 3, 2020
The company executed a 2-for-1 stock split, meaning that for every share held, investors received 2 new shares.
Before the split, OliX Pharmaceuticals Inc traded at 107700 per share. Afterward, the share price was about 51600.
The adjusted shares began trading on Dec 3, 2020. This was the only stock split in OliX Pharmaceuticals Inc's history.
